Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Aimee Payne
University of Pennsylvania, Department: Dermatology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cabaletta Bio, Inc. (formerly Tycho Therapeutics, Inc.)
Payment for services (e.g., consulting fees, honoraria, paid authorship)
NA
Engineering disease-specific T cells for pemphigus therapy
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially fatal autoimmune skin blistering diseases. We propose to use chimeric T cell receptor technology to engineer T cells to kill autoimmune B cells in pemphigus, a novel approach that we predict will lead to durable disease remission without risks from general immune suppression. This therapeutic strategy has never been tested in autoimmune disease and, if proven effective in pemphigus, could be applied to any autoantibody-mediated disease for which the target antigen is known.
Filed on July 22, 2019.
Tell us what you know about Aimee Payne's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Aimee Payne filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Aimee Payne | University of Pennsylvania | Conflict of Interest | Cabaletta Bio, Inc. (formerly Tycho Therapeutics, Inc.) | $100,000 - $149,999 |
| Aimee Payne | University of Pennsylvania | Conflict of Interest | Tycho Therapeutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.